PUBLISHER: Grand View Research | PRODUCT CODE: 1474870
PUBLISHER: Grand View Research | PRODUCT CODE: 1474870
The global PEEK implants market size is anticipated to reach USD 1,520.4 million by 2030, registering a CAGR of 7.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Polyetheretherketone (PEEK) implants are expected to become popular in the years to come due to their advantages, including their resistance to corrosion, low weight, and biocompatibility. In addition, there is a greater need for PEEK implants due to the trend of minimally invasive surgical techniques.PEEK implants are biocompatible, meaning they are well-tolerated by the body, reducing the risk of adverse reactions or rejection. This property makes these implants suitable for a wide range of medical applications, including orthopedic, spinal, and dental surgeries.
Overall, the rising product demand reflects the ongoing trend toward innovative biomaterials that offer advantages in terms of biocompatibility, mechanical properties, radiolucency, and versatility. As healthcare providers and patients increasingly recognize the product benefits, their adoption is expected to continue to grow across a wide range of medical specialties. PEEK polymers are mostly used in spinal implants as their radiolucency enables medical personnel to see the bone fusion through the implant. One of the main areas of concentration for top PEEK manufacturers is the spine market. Increased number of new product launches and company collaborations/acquisitions have been fueling market growth.
For instance, in 2022, Kumovis GmbH, a developer of additive manufacturing solutions for customized healthcare applications located in Munich, Germany, was acquired by 3D Systems Corporation. Kumovis' solutions are based on their proprietary extrusion process, which was created especially for high-performance, medical-grade polymers like PEEK to be printed precisely. Furthermore, the growing acceptance of PEEK implants by medical professionals and regulatory agencies has been a major factor in the expansion of the market. North America was the dominant regional market in 2023 and accounted for the largest market share of 41.5% in the same year. The market's expansion in North America is ascribed to the existence of significant industry participants, an increase in orthopedic disorders, and government endorsements of novel products.